CIK 0001484612
- Accelerated filer
- Smaller reporting company
Outset Medical, Inc.
Sign in to watch- Ticker
- OM
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 200514392
- Phone
- +1 669-231-8200
- Business address
- 3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
- Former names
- Home Dialysis Plus, Ltd.
- Open-market buys, last 90 days
- $870,260
- in 1 filing
- Open-market sales, last 90 days
- $28,997
- in 2 filings
Net +$841,264. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 50 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-01 | Trigg Leslie Chair and CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −20,000 | 75,711 | ||
| 2022-03-01 | Brottem John L. General Counsel | Sale | −1,003 | $43.73 | $44K | 36,806 |
| 2022-03-01 | Vazquez Martin Chief Operating Officer | Exercise or conversion | +5,000 | $8.62 | $43K | 55,525 |
| 2022-03-01 | Vazquez Martin Chief Operating Officer | Sale | −5,000 | $43.51 | $218K | 50,525 |
| 2022-03-01 | Vazquez Martin Chief Operating Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −5,000 | 62,151 | ||
| 2022-02-15 | Brottem John L. General Counsel | Exercise or conversion | +3,000 | $9.48 | $28K | 40,309 |
| 2022-02-15 | Brottem John L. General Counsel | Sale | −3,000 | $35.92 | $108K | 37,309 |
| 2022-02-15 | Brottem John L. General Counsel | Exercise or conversion | +7,002 | $9.48 | $66K | 44,311 |
| 2022-02-15 | Brottem John L. General Counsel | Sale | −7,002 | $35.92 | $251K | 37,309 |
| 2022-02-15 | Brottem John L. General Counsel | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,002 | 45,224 | ||
| 2022-02-15 | Brottem John L. General Counsel | Exercise or conversion · Performance Options (right to buy) | −3,000 | 4,265 | ||
| 2022-02-02 | Trigg Leslie Chief Executive Officer | Grant or award | +11,706 | 311,113 | ||
| 2022-02-01 | Vazquez Martin Chief Operating Officer | Exercise or conversion | +5,000 | $8.62 | $43K | 55,525 |
| 2022-02-01 | Vazquez Martin Chief Operating Officer | Sale | −5,000 | $37.44 | $187K | 50,525 |
| 2022-02-01 | Vazquez Martin Chief Operating Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −5,000 | 67,151 | ||
| 2022-02-01 | Trigg Leslie Chief Executive Officer | Exercise or conversion | +20,000 | $3.88 | $78K | 319,407 |
| 2022-02-01 | Trigg Leslie Chief Executive Officer | Sale | −20,000 | $37.50 | $750K | 299,407 |
| 2022-02-01 | Trigg Leslie Chief Executive Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −20,000 | 95,711 | ||
| 2022-01-26 | Williamson Steven S. Chief Commercial Officer | Grant or award | +27,350 | 63,207 | ||
| 2022-01-26 | Williamson Steven S. Chief Commercial Officer | Grant or award | +1,538 | 64,745 |
Page 24 of 34 · 678 trades